Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-053468
Filing Date
2026-08-05
Accepted
2026-08-05 16:56:42
Documents
69
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eols-20260630.htm   iXBRL 10-Q 1378090
2 EX-10.1 ex10110q63026.htm EX-10.1 35888
3 EX-31.1 exhibit311q22026.htm EX-31.1 10523
4 EX-31.2 exhibit312q22026.htm EX-31.2 10739
5 EX-32.1 exhibit321q22026.htm EX-32.1 7759
  Complete submission text file 0001628280-26-053468.txt   7633134

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20260630.xsd EX-101.SCH 58100
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20260630_cal.xml EX-101.CAL 79134
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20260630_def.xml EX-101.DEF 325288
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20260630_lab.xml EX-101.LAB 667824
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20260630_pre.xml EX-101.PRE 469957
73 EXTRACTED XBRL INSTANCE DOCUMENT eols-20260630_htm.xml XML 912345
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 261244524
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)